MBOT

Microbot Medical Inc. [MBOT] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

MBOT Stock Summary

The Moving Average Convergence Divergence (MACD) for MBOT recently turned positive (within last 10 days).

Does not have any significance market cap ($14.54M)

Top 10 Correlated ETFs

MBOT

Top 10 Correlated Stocks

MBOT

In the News

MBOT Financial details

Company Rating

Market Cap

14.54M

Income

-10.67M

Revenue

Book val./share

Cash/share

Dividend

Dividend %

Employees

Optionable

Shortable

Yes

Earnings

15 May 2024

P/E

0.15

Forward P/E

PEG

-0.01

P/S

P/B

2.28

P/C

P/FCF

-1.82

Quick Ratio

5.47

Current Ratio

5.64

Debt / Equity

LT Debt / Equity

EPS (TTM)

-1.08

EPS next Y

EPS next Q

EPS this Y

-107.27%

EPS next Y

EPS next 5Y

EPS last 5Y

Revenue last 5Y

Revenue Q/Q

EPS Q/Q

28.57%

SMA20

SMA50

SMA100

100%

Inst Own

Inst Trans

ROA

1248%

ROE

1532%

ROC

-1.47%

Gross Margin

Oper. Margin

Profit Margin

Payout

Shs Outstand

Shs Float

Target Price

52W Range

1.0-4.37

52W High

-42.25%

52W Low

+131%

RSI

Rel Volume

1.96

Avg Volume

98.01K

Volume

192.32K

Perf Week

3.59%

Perf Month

62.68%

Perf Quarter

137.14%

Perf Half Y

132.02%

Beta

1.648

Volatility

0.12%, 0.36%

Prev Close

3.59%

Price

2.31

Change

-6.48%

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 98.01K
Market Capitalization 14.54M
Employee 21
CEO Mr. Harel Gadot
Headquarters Hingham,MA,US
IPO Date 1992-03-25
Website https://www.microbotmedical.com

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.